Public Release: 

Weight and height during adolescence may impact future risk of developing Non-Hodgkin's lymphoma


A new analysis indicates that higher body weight and taller stature during adolescence increase the risk of developing Non-Hodgkin's Lymphoma (NHL), a type of cancer of the lymphatic system. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Rates of NHL have increased worldwide, and research suggests that rising rates of obesity may be contributing to this trend. With this in mind, a team led by Merav Leiba, MD, of the Sheba Medical Center in Israel, examined whether adolescent weight and height might be associated with the risk of developing NHL later in life. The study included 2,352,988 teens aged 16 to 19 years old who were examined between 1967 and 2011. Their information was linked to the Israel National Cancer Registry, which included 4021 cases of NHL from 1967 through 2012.

Adolescent overweight and obesity was associated with a 25 percent increased risk of NHL in later life, compared with normal weight, and there was an association for multiple subtypes of NHL. "Obesity and overweight during adolescence are risk factors for future Non-Hodgkin Lymphoma," said Dr. Leiba. "It is important to be aware that overweight and obesity are not risk factors only for diabetes and cardiovascular disease but also for lymphomas."

There was also a stepwise gradient in NHL risk with increasing height. When compared with the mid-range height category, shorter individuals had a 25 percent reduced risk of NHL, whereas the tallest individuals had a 28 percent increased risk. In the end, excess height and weight were responsible for 6% and 3% of all NHL cases respectively. As for mechanism, height and excess nutrition in childhood may have impacts on inflammatory molecules and growth factors that could support the development of NHL, but additional studies are needed to investigate these possibilities.


Article: "Adolescent weight and height are predictors of specific Non-Hodgkin's Lymphoma subtypes among a cohort of 2,352,988, 16-19 year olds." Merav Leiba, Adi Leiba, Lital Keinan-Boker, Abraham Avigdor, Estela Derazne, Hagai Levine, and Jeremy D. Kark. CANCER; Published Online: February 22, 2016 (DOI: 10.1002/cncr.29792).

URL Upon Publication:

Author Contact: Lee Gat of the Sheba Medical Center public inquiries service at or 97 03-530 3296.

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at

Follow us on Twitter @JournalCancer and Facebook

About Wiley

Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Research segment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Development segment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content. The Company's website can be accessed at

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.